BioSpace News Archive

Partial onset seizure occurs due to abnormal electrical activity in one part of the brain. It is also known as focal seizure.

A vaccine is a biological product which gives active acquired immunity to a particular disease.Vaccines have always been considered as a less profitable business described by high entrance hurdles.

Rapid growth in the field of information technology has brought in a rise in the demand for hospital administration software for the medical industry.

Fluidigm Corporation, an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced financial results for the fourth quarter and full year ended December 31, 2020.

Envista Holdings Corporation (NYSE: NVST) today announced results for the fourth quarter 2020.

Combined company renamed Nuvation Bio Inc., will be listed on the New York Stock Exchange under ticker symbol “NUVB” Strong cash position of approximately $830 million includes approximately $646 million held in Panacea’s trust account and from concurrent private financings NEW YORK , Feb. 10, 2021 /PRNewswire/ -- Nuvation Bio I

TherapeuticsMD, Inc. (NASDAQ:TXMD) today announced an underwritten public offering of its common stock.

Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it plans to make a public offering of 3,000,000 shares of its common stock,

Infinity Pharmaceuticals, Inc . (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, which addresses a fundamental biologic mechanism of immune suppression in cancer, today announced that it will hold a conference call on Thursday, February 11, 2021 at 7:30 a.m. ET

Core One Labs Inc. a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines to market, is pleased to announce preparations for filing a patent application encompassing its proprietary biosynthetic psilocybin production system.